Strength of recommendation for various interventions in the sample case of an elderly woman admitted to an LTC facility after sustaining a hip fracture
| INTERVENTIONS GROUPED BY STRENGTH OF RECOMMENDATION* | N/N (%) |
|---|---|
| Strongly or very strongly recommended | |
| • Calcium | 114/119 (96) |
| • Vitamin D | 116/120 (97) |
| • Oral aminobisphosphonates (eg, alendronate, risedronate) | 104/116 (90) |
| • Physical therapy or exercise | 115/119 (97) |
| • Environmental modification (eg, bathroom handrails) | 117/119 (98) |
| Not recommended or limited use† | |
| • Oral etidronate | 80/107 (75) |
| • Intravenous bisphosphonates | 90/112 (80) |
| • Calcitonin | 102/116 (88) |
| • Raloxifene | 99/113 (88) |
| • Testosterone treatment (for a hypogonadal man) | 87/111 (78) |
| • Teriparatide | 94/109 (86) |
| Not recommended or discouraged use | |
| • Postmenopausal hormone therapy | 95/115 (83) |
LTC—long-term care.
↵* Support was mixed for the following interventions: hip protectors and B vitamins with folate (ie, homocysteine-lowering therapy). For these interventions, responses ranged from do not recommend to strongly recommend for the most frequent categories selected, suggesting strongly conflicting views among participants.
↵† Limited use of an intervention was defined by use of the intervention if other treatments were not tolerated or were contraindicated.